1239091

Matthew Johnston MD — FEI 3017153476

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 10, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Salt Lake City, UT (United States)

Additional Details

Clinical BA/BE